TGFB1 and metabolic dysfunction-associated steatohepatitis: A pioneer research published in 2006 compared the levels of serum concentrations of transforming growth factor-beta1 (TGF-β1) a marker of fibrosis, and ferritin between NAFL, and NASH patients [40].